Cargando…

Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients

Background Platelet transfusion is a life-saving procedure for thrombocytopenic patients. Platelet transfusions can be either prophylactic or therapeutic. Prophylactic platelet transfusion reduces the risk of bleeding before any specific procedure, whereas therapeutic platelet transfusion helps to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad Sahu, Dhananjay, Wasnik, Minal, Kannauje, Pankaj K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614500/
https://www.ncbi.nlm.nih.gov/pubmed/37908942
http://dx.doi.org/10.7759/cureus.46161
_version_ 1785129043254837248
author Prasad Sahu, Dhananjay
Wasnik, Minal
Kannauje, Pankaj K
author_facet Prasad Sahu, Dhananjay
Wasnik, Minal
Kannauje, Pankaj K
author_sort Prasad Sahu, Dhananjay
collection PubMed
description Background Platelet transfusion is a life-saving procedure for thrombocytopenic patients. Platelet transfusions can be either prophylactic or therapeutic. Prophylactic platelet transfusion reduces the risk of bleeding before any specific procedure, whereas therapeutic platelet transfusion helps to control active bleeding. Evaluation of the response to platelet transfusion by calculating the corrected count increment (CCI) is important to determine the success of platelet transfusion and to plan subsequent patient management. Methods We conducted a prospective observational study in patients who received at least one unit of platelet concentrate (random donor platelet (RDP) or single donor platelet (SDP)) admitted under or seen by General Medicine. Patients over 60 years, multiparous females, and chemotherapy patients were excluded. The patient's pre-transfusion and post-transfusion platelet counts at one hour and 24 hours were taken, and CCI was calculated. Results We studied 60 patients during the study period, out of which 35 were males (58.33%) and 25 were females (41.67%). The mean age was 36.2 years, and the age range was from 15 to 60 years. The majority of patients were O-Rh positive (41.67%), followed by B-Rh positive (40%), A-Rh positive (11.67%), and least by AB-Rh positive (5%) and only one patient with O-Rh negative (1.67%). The logistic regression analysis showed that sepsis (p=0.025), splenomegaly (p=0.004), COVID-19 (p=0.016), dengue (p=0.028), systemic lupus erythematosus (SLE) (p=0.045), immune thrombocytopenic purpura (ITP) (p=0.003) and fever (p=0.007) significantly contributed to unsuccessful CCI. However, acute leukemia (p=0.238), active bleeding (p=0.147), disseminated intravascular coagulopathy (DIC) (p=0.952), aplastic anemia (AA) (p=0.114), and sickle cell disease (SCD) (p=0.739) did not show any statistical significance. Conclusion Unsuccessful CCI at 24 hours is attributed to non-immunological clinical factors like sepsis, splenomegaly, COVID-19, and fever, whereas immunological clinical factors like SLE, dengue, and ITP resulted in unsuccessful CCI at one hour, as evident by this study.
format Online
Article
Text
id pubmed-10614500
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-106145002023-10-31 Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients Prasad Sahu, Dhananjay Wasnik, Minal Kannauje, Pankaj K Cureus Oncology Background Platelet transfusion is a life-saving procedure for thrombocytopenic patients. Platelet transfusions can be either prophylactic or therapeutic. Prophylactic platelet transfusion reduces the risk of bleeding before any specific procedure, whereas therapeutic platelet transfusion helps to control active bleeding. Evaluation of the response to platelet transfusion by calculating the corrected count increment (CCI) is important to determine the success of platelet transfusion and to plan subsequent patient management. Methods We conducted a prospective observational study in patients who received at least one unit of platelet concentrate (random donor platelet (RDP) or single donor platelet (SDP)) admitted under or seen by General Medicine. Patients over 60 years, multiparous females, and chemotherapy patients were excluded. The patient's pre-transfusion and post-transfusion platelet counts at one hour and 24 hours were taken, and CCI was calculated. Results We studied 60 patients during the study period, out of which 35 were males (58.33%) and 25 were females (41.67%). The mean age was 36.2 years, and the age range was from 15 to 60 years. The majority of patients were O-Rh positive (41.67%), followed by B-Rh positive (40%), A-Rh positive (11.67%), and least by AB-Rh positive (5%) and only one patient with O-Rh negative (1.67%). The logistic regression analysis showed that sepsis (p=0.025), splenomegaly (p=0.004), COVID-19 (p=0.016), dengue (p=0.028), systemic lupus erythematosus (SLE) (p=0.045), immune thrombocytopenic purpura (ITP) (p=0.003) and fever (p=0.007) significantly contributed to unsuccessful CCI. However, acute leukemia (p=0.238), active bleeding (p=0.147), disseminated intravascular coagulopathy (DIC) (p=0.952), aplastic anemia (AA) (p=0.114), and sickle cell disease (SCD) (p=0.739) did not show any statistical significance. Conclusion Unsuccessful CCI at 24 hours is attributed to non-immunological clinical factors like sepsis, splenomegaly, COVID-19, and fever, whereas immunological clinical factors like SLE, dengue, and ITP resulted in unsuccessful CCI at one hour, as evident by this study. Cureus 2023-09-28 /pmc/articles/PMC10614500/ /pubmed/37908942 http://dx.doi.org/10.7759/cureus.46161 Text en Copyright © 2023, Prasad Sahu et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Prasad Sahu, Dhananjay
Wasnik, Minal
Kannauje, Pankaj K
Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients
title Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients
title_full Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients
title_fullStr Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients
title_full_unstemmed Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients
title_short Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients
title_sort factors influencing corrected count increment after platelet transfusion in thrombocytopenic patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614500/
https://www.ncbi.nlm.nih.gov/pubmed/37908942
http://dx.doi.org/10.7759/cureus.46161
work_keys_str_mv AT prasadsahudhananjay factorsinfluencingcorrectedcountincrementafterplatelettransfusioninthrombocytopenicpatients
AT wasnikminal factorsinfluencingcorrectedcountincrementafterplatelettransfusioninthrombocytopenicpatients
AT kannaujepankajk factorsinfluencingcorrectedcountincrementafterplatelettransfusioninthrombocytopenicpatients